Should You Hold CV Sciences Inc (CVSI) in Drug Manufacturers

A rating of 51 puts CV Sciences Inc (CVSI) near the middle of the Drug Manufacturers - Specialty & Generic industry according to InvestorsObserver. CV Sciences Inc's score of 51 means it scores higher than 51% of stocks in the industry. CV Sciences Inc also received an overall rating of 40, putting it above 40% of all stocks. Drug Manufacturers - Specialty & Generic is ranked 107 out of the 148 industries.

CVSI has an Overall Score of 40. Find out what this means to you and get the rest of the rankings on CVSI!

See Full CVSI Report

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 40 would rank higher than 40 percent of all stocks. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With CV Sciences Inc Stock Today?

CV Sciences Inc (CVSI) stock is unchanged -2.67% while the S&P 500 has gained 0.13% as of 11:25 AM on Monday, Nov 6. CVSI is flat $0.00 from the previous closing price of $0.04 on volume of 658,953 shares. Over the past year the S&P 500 is higher by 14.63% while CVSI is flat 0.00%. CVSI earned $0.01 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 5.42. Click Here to get the full Stock Report for CV Sciences Inc stock.